biote Corp. (BTMD)
1.47
-0.04
(-2.65%)
USD |
NASDAQ |
Sep 09, 16:00
1.47
0.00 (0.00%)
After-Hours: 18:10
biote Enterprise Value : 166.84M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 166.84M |
| September 04, 2026 | 167.81M |
| September 03, 2026 | 167.95M |
| September 02, 2026 | 171.82M |
| September 01, 2026 | 171.26M |
| August 31, 2026 | 170.44M |
| August 28, 2026 | 168.50M |
| August 27, 2026 | 170.16M |
| August 26, 2026 | 167.95M |
| August 25, 2026 | 168.78M |
| August 24, 2026 | 168.50M |
| August 21, 2026 | 169.61M |
| August 20, 2026 | 166.01M |
| August 19, 2026 | 162.69M |
| August 18, 2026 | 161.03M |
| August 17, 2026 | 162.97M |
| August 14, 2026 | 165.73M |
| August 13, 2026 | 166.29M |
| August 12, 2026 | 164.35M |
| August 11, 2026 | 167.67M |
| August 10, 2026 | 167.67M |
| August 07, 2026 | 166.01M |
| August 06, 2026 | 170.16M |
| August 05, 2026 | 187.59M |
| August 04, 2026 | 187.86M |
| Date | Value |
|---|---|
| August 03, 2026 | 188.42M |
| July 31, 2026 | 187.31M |
| July 30, 2026 | 186.48M |
| July 29, 2026 | 181.50M |
| July 28, 2026 | 187.03M |
| July 27, 2026 | 189.52M |
| July 24, 2026 | 188.14M |
| July 23, 2026 | 187.31M |
| July 22, 2026 | 190.07M |
| July 21, 2026 | 194.78M |
| July 20, 2026 | 193.95M |
| July 17, 2026 | 192.29M |
| July 16, 2026 | 190.90M |
| July 15, 2026 | 185.10M |
| July 14, 2026 | 185.65M |
| July 13, 2026 | 189.24M |
| July 10, 2026 | 189.52M |
| July 09, 2026 | 188.14M |
| July 08, 2026 | 187.59M |
| July 07, 2026 | 187.31M |
| July 06, 2026 | 188.14M |
| July 02, 2026 | 185.10M |
| July 01, 2026 | 180.12M |
| June 30, 2026 | 177.35M |
| June 29, 2026 | 161.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cannabis Strategic Ventures, Inc. | 4.180M |
| Rafael Holdings, Inc. | 101.87M |
| Concentra Group Holdings Parent, Inc. | 6.335B |
| Elite Health Systems, Inc. | 24.39M |
| U.S. Stem Cell, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.428M |
| Revenue (Quarterly) | 44.23M |
| Total Expenses (Quarterly) | 50.80M |
| EPS Diluted (Quarterly) | -0.2293 |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | -16.79% |
| Earnings Yield | 8.19% |
| Operating Earnings Yield | 45.48% |
| Normalized Earnings Yield | 13.56 |